Inherited metabolic disorders and dyslipidaemia
- PMID: 31757783
- DOI: 10.1136/jclinpath-2019-205910
Inherited metabolic disorders and dyslipidaemia
Abstract
Monogenic dyslipidaemia is a diverse group of multisystem disorders. Patients may present to various specialities from early childhood to late in adult life, and it usually takes longer before the diagnosis is established. Increased awareness of these disorders among clinicians is imperative for early diagnosis. This best practice review provides an overview of primary dyslipidaemias, highlighting their clinical presentation, relevant biochemical and molecular tests. It also addresses the emerging role of genetics in the early diagnosis and prevention of these disorders.
Keywords: inherited pathology; lipids; lipoproteins.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
The role of the Clinical Chemistry laboratory in facilitating earlier diagnosis of dyslipidaemia-associated inherited metabolic disease.J Clin Pathol. 2020 Jul;73(7):363-365. doi: 10.1136/jclinpath-2019-206254. Epub 2020 May 20. J Clin Pathol. 2020. PMID: 32434768 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical